Critical pathways exist in many hospitals for treating patients with a suspected or confirmed diagnosis of venous thromboembolism (VTE). Some pathways call for “baseline laboratory studies,” including ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of ...

New York, NY, October 19, 2004 – Researchers at the Hospital for Special Surgery (HSS) in New York City have identified a potentially valuable therapeutic pathway for preventing miscarriages in ...

Venous thromboembolism (VTE) is a serious and potentially life-threatening complication of surgery. An Enhanced Recovery After Surgery (ERAS) program is a multimodal care pathway meant to facilitate ...

An international team of researchers led by MIT has explained how contaminated batches of the blood-thinner heparin were able to slip past traditional safety screens and kill dozens of patients ...

Overview: Heparin is a blood thinner that is used to prevent or treat blood clots. It may be injected under the skin or into a blood vessel. The most common side effects are irritation at the ...

Heparin injectable solution only comes as a generic drug. It doesn’t have a brand-name version. Heparin comes in two forms. One is an injectable solution, which you inject under your skin. The other ...

This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...

A serious but very rare adverse effect. This is the scientific consensus that has emerged after both the European and British regulators examined the association of unusual blood clotting events ...

CAMBRIDGE, Mass.--An international team of researchers led by MIT has explained how contaminated batches of the blood-thinner heparin were able to slip past traditional safety screens and kill dozens ...